Navigation Links
Precision Antibody Expands Antibody Characterization Services
Date:3/15/2012

COLUMBIA, Md., March 15, 2012 /PRNewswire-iReach/ -- Precision Antibody, a market leader in contract antibody services, announced today that they have expanded their antibody characterization services to include Fortebio's  Octet RED96™ system, a multi-functional, label-free, real-time binding analysis instrument.  

Since 2006, Precision Antibody has been providing antibody characterization services using Biacore™ 3000 by GE Healthcare, a Surface Plasmon Resonance (SPR) based real time binding kinetic analysis machine.  We are now proud to announce the addition of the Octet RED96 from ForteBio to enhance our cutting edge antibody characterization capabilities and services. The Octet Red96 uses Bio-Layer Interferometry (BLI) technology for the detection of label-free real time molecular interaction analysis.

The Octet Red96 can perform up to 8 label-free binding assays at one time, allowing high throughput antibody screening and characterization.   The technology is fully integrated into Precision Antibody's custom monoclonal antibody development platform to aid the selection of suitable application-specific clones otherwise missed in a conventional EIA based screening format.

Octet Red96 can be used for the screening of monoclonal antibodies using unlabeled free antigen in solution, antibody quantification, affinity based antibody ranking, epitope binning, full binding kinetic analysis, and more.  Binding kinetic analyses can be performed with molecules as small as 150 Dalton.

"We are excited to offer an additional cutting edge technology to our customers. Together with our state-of-the-art monoclonal antibody development platform technology, we continue to deliver the highest quality antibodies to our customers" says Jun Hayashi, Ph.D., the VP of Precision Antibody.

About Precision Antibody (www.precisionantibody.com)

Precision Antibody™ provides customized, high-affinity monoclonal and polyclonal antibodies to pharmaceutical and biotechnology companies as well as to academic, government, and nonprofit research institutions.  Precision Antibody™ develops antibodies for the use in research and discovery, for the development of preclinical therapeutic and diagnostic targets, and for QC and PK studies. The company's products and services are based on a proprietary antibody discovery and development platform technology that enables rapid development of target-specific, high-affinity antibodies. Precision Antibody™ provides one-stop service for antibody development, characterization (isotype and affinity determination), purification/production (from pilot to large scale), and conjugation, as well as stable cell line development and hybridoma cell banking. Precision Antibody™ is a wholly owned service division of A&G Pharmaceutical, Inc. (www.agpharma.com ) and is based in Columbia, MD.

About Octet RED96™ & Biacore™

Octet RED96™ is a registered trademark of ForteBio, Inc.  Precision Antibody is not affiliated with ForteBio, Inc. products or services.  Biacore™ is a registered trademark of GE Healthcare. Precision Antibody is not affiliated with GE Healthcare products or services.

Media Contact: Michael Keefe, Precision Antibody, 410-884-4100, mkeefe@precisionantibody.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Precision Antibody
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
2. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
3. Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System
4. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
5. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
6. TechPrecision Corporations WCMC Division Adds Second Sapphire Customer
7. Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
8. FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays
9. Precision Therapeutics Named on Inc. 500
10. 5000 2011 List and Recognized for Achievements in Personalized Medicine Industry
11. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Aug. 15, 2017 AccuGenomics, Inc., a diagnostic ... today announced that the company has provided an AccuKit ... North Carolina at Chapel Hill and to Qura Therapeutics ... characterize and quantify HIV reservoir and viral expression in ... The HIV Cure Center is a joint initiative between ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
Breaking Medicine Technology:
(Date:8/21/2017)... ... , ... PIXACORE , an independent full-service agency with a decade of ... the year by MM&M. , This is the first time PIXACORE has made the ... agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth and recent strategic ...
(Date:8/21/2017)... ... ... The Industrial Designers Society of America (IDSA) hosted the ... Aug. 19, 2017 in Atlanta, GA—revealing which 25 designs won Gold and which 52 ... See all the winners at http://www.idsa.org/awards/idea/gallery . , “I hope you’re as excited ...
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with gluten ... so, you may be interested in participating in a research study that focuses on ... to understand more about the relational aspects of adults who have gluten sensitivities who ...
(Date:8/19/2017)... ... August 18, 2017 , ... President Donald Trump signed into ... provides for greater public access to over-the-counter (OTC) hearing aids. , The measure ... aids without being seen by a certified and licensed audiologist. , “The ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the United States retracted ... sides. There are not two sides to hatred, bigotry, discrimination, and a white supremacy ... the NPEIV stands against all forms of such hatred and discrimination in this country ...
Breaking Medicine News(10 mins):